key: cord-0779074-b2znv6pa authors: Ma, Y.; Diao, B.; Lv, X.; Zhu, J.; Liang, W.; Liu, L.; Bu, W.; Cheng, H.; Zhang, S.; Shi, M.; Ding, G.; Shen, B.; Wang, H. title: 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China date: 2020-02-25 journal: nan DOI: 10.1101/2020.02.24.20027201 sha: 8dbfb1122839fd2802805136525b502f9dc74d28 doc_id: 779074 cord_uid: b2znv6pa The outbreak of COVID-19 originated in Wuhan has become a global epidemic of contagious diseases, which poses a serious threat to human life and health, especially for those with underlined diseases. However, Impacts of COVID-19 epidemic on HD center and HD patients are still unknown. In this report, we reviewed the whole course of the epidemic emerged in the HD center of Renmin Hospital, Wuhan University from January 14, 2020, the day the first case was confirmed, to February 17, 2020, the day the epidemic extinction. There are totally 37 cases among 230 HD patients and 4 cases among 33 staff being diagnosed with COVID-19. The epidemiology, clinical presentation and immune profile of dialysis patients contracted COVID-19 were further studied. We found that the two key measures we took in response to the epidemic, one was upgrading level of prevention and protection on January 21 and the other one starting universal screening, isolating, and distributing the infected cases on February 4, were effective in the epidemic control. No new COVID-19 case had been diagnosed since February 13. During the epidemic, 7 HD patients died, including 6 with COVID-19 and 1 without COVID-19. The presumed causes of death were not directly related to pneumonia, but due to cardiovascular and cerebrovascular diseases, hyperkalemia, etc. Most of the leukocytes in the peripheral blood of the HD patients infected with COVID-19 decreased, and the CT images of the chest mostly showed the ground glass like changes on the right side. The symptoms of most of the patients were mild, and there were no cases admitted to ICU. The frequency of lymphocytes in PBMCs and the serum level of inflammatory cytokines were assessed in HD patients contracted COVID-19 or not, non-HD COVID-19 patients, as well as healthy volunteers. The results showed that lymphocytes of T cell, Th cells, killer T cells, as well as NK cells in PBMCs of HD patients decreased significantly than other groups. HD patients with COVID-19 also displayed remarkable lower serum level of inflammatory cytokines than other COVID-19 patients. Our study indicates that HD patients are the highly susceptible population and HD centers are high risk area in the outbreak of COVID-19 epidemic. Measures of prevention, protection, screening, isolation, and distribution are essential in the epidemic management and should be taken in the early stage. HD Patients with COVID-19 are mostly clinical mild and unlikely progress to severe pneumonia due to the impaired cellular immune function and incapability of mounting cytokines storm. More attention should be paid to prevent cardiovascular events, which may be the collateral impacts of COVID-19 epidemic on HD patients. In December 2019, the initially outbreak of COVID-19 in Wuhan city spread rapidly to all over China and even the world, becoming a serious pandemic [1] [2] [3] . As of February 17, 2020, the confirmed COVID-19 case in Wuhan city, nationwide of China, and world globally reached to 37152, 70635, and 71429 respectively [4, 5] . In the patients with COVID-19, some special population should be paid special attention to. Epidemiological survey shows that COVID-19 patients with underlined conditions such as diabetes, hypertension, cardiovascular disease or the elderly are not only susceptible, but also often more serious. These patients are at higher risk of admission to intensive care or death [6, 7] . In addition, the profound impact inflicted by COVID-19 on pregnant women and newborns has also been noticed [8, 9] . However, as far as we know, the impact of COVID-19 epidemic on chronic kidney disease patients, especially uremic HD patients has not yet been reported. Considering the large population size of HD patients (There are 7184 registered patients receiving HD treatment in 61 centers in Wuhan city.), the high aggregation and mobility of HD center population, and the low immune function of uremic patients [10] , the situation of HD patients under the COVID-19 epidemic should not be ignored. In this study, we described an outbreak of COVID-19 in one HD center in Renmin Hospital of Wuhan University, which is located in the downtown of Wuhan city of China. A cluster of HD patients contracted COVID-19 were surveyed and followed until the day on February 17, 2020. The epidemiological, clinical, laboratory, and radiological characteristics, and outcomes of some of these patients were reviewed. We expect our findings will shed light on the appropriate management of the HD center and HD patients in face of COVID-19 or other similar epidemic emerging. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The medical records of all participants were analyzed by the research team of the Department of Nephrology, Renmin Hospital of Wuhan University. Epidemiological, clinical, laboratory, and radiological characteristics and outcomes data were obtained with data collection forms from electronic medical records or specific data questionnaire. Some data were retrieved from the Hubei Province kidney disease quality control information platform. The data were reviewed by a trained team of physicians. Information collected including demographic data, medical history, underlying comorbidities, symptoms, signs, blood routine test, chest computed tomographic (CT) scans. During the period of follow up, the odd episode of death happened among these patients were recorded and the presumed cause of death were proposed by the research team, based on the time, place and clinical manifestation of the death. The SARS-CoV-2 detection was done by real-time PCR (RT-PCR) as described previously [12] . Briefly, nasopharyngeal swab samples of participants were collected for SARS-CoV-2 test with the detection kit (Bioperfectus, Taizhou, China). The is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint condition. Measurement data were expressed using median and interquartile range (IQR) values and compared using independent group t test. Enumeration data were described as number (%). All statistical analyses were performed using SPSS (Statistical Package for Statistical analysis), and a P value of less than 0.05 is considered as significant difference. 230 patients and 33 staff in our HD center were included in this study. The dynamic course of COVID-19 epidemic from emerging to development is schematic presented in Figure 1 . We can see that the first COVID-19 patient was diagnosed on January 14, and the second diagnosed patient appeared on January 17. Since January 21, patients with COVID-19 had been requested to be isolated and all medical staff had be asked to upgrade their personal prevention and protection, which including wearing full protective gear such as waterproof disposable gown, cap, gloves, face shield, and N95 face mask, and more rigorous cleaning and disinfection. On Figure 2 summarize the management flow and the outcomes of the followed cluster in the epidemic. It showed that 37 patients were diagnosed with COVID -19 of which 6 patients had died (Figure 2A) . The other . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint treatment. 4 medical staffs with COVID-19 were treated in isolation wards. There are totally 7 episodes of death were recorded since the epidemic outbreak, 2 happened in hospital and 5 at home. Among the 7 died cases, 6 were HD patients with COVID-19 and the other one was COVID-19 free ( Figure 2B ). All of the death were followed and reviewed by our research team, the presumed cause of death was heart failure, hyperkalemia and cerebrovascular disease, and none of them succumbed to severe pneumonia based on the appearance of death ( Figure 2B ). 37 HD patients with COVID-19 demographic and biochemical clinical data were summarized in Table 1 . In total, 23 (62%) men and 14 (38%) women were concluded. The median age of all patients was 66 years (IQR, 55-81), and the median HD age was 34 months (IQR, 13-61). Meanwhile, all clinical data involving dry weight, hemoglobin, albumin, blood calcium, blood phosphorus, blood intact parathyroid hormone (iPTH) and Kt/V Urea values were also listed in Table 1 . Unlike previous studies, the clinical symptoms of HD patients with COVID-19 were not obvious since the medical records showed that 4 (11%) patients had fever, 3 (8%) patients had fatigue, and only 1 (3%) patient had the symptom of cough, chest pain or nausea respectively (Table 2) . Besides, no other symptoms were observed in these patients. According to chest CT scans reports, 15 (41%) patients showed unilateral involvement (13 cases in right lung and 2 cases in left lung) and 22 (59%) patients showed bilateral involvement. 23 (62%) patients had multiple "ground-glass opacity" lesions in the lung which were regarded as the characteristics of COVID-19 pneumonia (Table 3 and Figure 3 ). The immune system is the key defense line for the body to resist and eliminate the virus. In the antiviral immune response, cellular immunity (including T cells and NK cells) plays a central role, while humoral immunity plays a coordinating role. The underlined mechanism of SARS-CoV-2 inflicted harmful effects leading to severe condition or death in COVID-19 patients is the over response against the virus by immune system and large amount of cytokines production (cytokine storm) [13] . The above results show that most of the HD patients with SARS-CoV-2 infection were in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint relatively mild condition. We speculated that this might be related to the special immune dysfunction of HD patients. Therefore, we detected the frequency of T cell, in our center imply that, although SARS-CoV-2 is highly infectious, it can still get control through strict and standardized protective measures, as well as timely patient screening based on chest CT result, and followed patient distribution and isolation. During the outbreak of COVID-19 in our center, 7 episode of death were recorded, with a mortality of 3%, which is far higher than that of the same period in history. The high mortality is obviously related to the epidemic situation. However, it was found that no one patient died of pneumonia directly after tracing the causes of death of 7 patients. The main causes of death were cardiovascular and cerebrovascular complications or hyperkalemia, which was presumed due to the reduction of dialysis times for fear of contracting the virus. It should be noted that although HD patients are highly susceptible to COVID-19, the infection for them is likely less severe or fatal. Actually, none of the 37 infected patients in our center has been admitted to ICU due to severe pneumonia. Some infected patients even have no obvious clinical symptoms. These suggest that in the face of the COVID-19 epidemic emerging, measures of prevention and protection certainly should be taken to avoid infection, but the sufficient dialysis remains the key issue for patients to survive the epidemic. During the outbreak of SARS in 2003, it was observed that the severity and mortality of HD patients infected with SARS-CoV were similar to other infected population, but the duration of shedding virus through stool or breath was significantly longer than other patients [18] . Considering the high biological similarity between Tables Table 1 Demographics and baseline characteristics of 37 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.24.20027201 doi: medRxiv preprint A Novel Coronavirus from Patients with Pneumonia in China Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate Latest updates on COVID-19 from the European Centre for Disease Prevention and Control World Health Organization, Coronavirus disease 2019 (COVID-19) Situation Report -31 National Health Commission of the People`s Republic of China, COVID-19 epidemic situation report Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units End-stage renal disease, dialysis, kidney transplantation and their impact on CD4(+) T-cell differentiation New coronavirus pneumonia prevention and control program Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv Clinical features of patients infected with 2019 novel coronavirus in Wuhan National Health Commission Of The People S Republic Of China, COVID-19 epidemic situation report Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology Severe acute respiratory syndrome in dialysis patients Molecular aspects of T-and B-cell function in uremia Impaired cellular immune function in patients with end-stage renal failure Effect of uremia on structure and function of immune system